Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Pharmacology/Therapy

Foretinib inhibits cancer stemness and gastric cancer cell proliferation by decreasing CD44 and c-MET signaling

OncoTargets and Therapy | Feb 08, 2020 Pharmacology/Therapy

Ropeginterferon alfa-2b vs standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): A randomised, non-inferiority, phase 3 trial and its extension study

The Lancet Haematology | Feb 08, 2020 Pharmacology/Therapy

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

The Lancet Oncology | Feb 07, 2020 Pharmacology/Therapy

Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia

Cancer | Feb 07, 2020 Pharmacology/Therapy

Aggressive multimodal treatment and metastatic colorectal cancer survival

Journal of the American College of Surgeons | Feb 07, 2020 Pharmacology/Therapy

Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study

European Journal of Surgical Oncology | Feb 07, 2020 Pharmacology/Therapy

Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma

American Journal of Surgery | Feb 07, 2020 Pharmacology/Therapy

Bevacizumab in combination with either FOLFOX-4 or XELOX-2 in first-line treatment of patients with metastatic colorectal cancer: A multicenter randomized phase II trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

Clinical Colorectal Cancer | Feb 07, 2020 Pharmacology/Therapy

Expenditures for first- and second-generation tyrosine kinase inhibitors before and after transition of imatinib to generic status

JAMA | Feb 06, 2020 Pharmacology/Therapy

Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy

Menopause | Feb 06, 2020 Pharmacology/Therapy

« Prev 1 … 91 92 93 94 95 … 375 Next »

Foretinib inhibits cancer stemness and gastric cancer cell proliferation by decreasing CD44 and c-MET signaling

Ropeginterferon alfa-2b vs standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): A randomised, non-inferiority, phase 3 trial and its extension study

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia

Aggressive multimodal treatment and metastatic colorectal cancer survival

Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study

Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma

Bevacizumab in combination with either FOLFOX-4 or XELOX-2 in first-line treatment of patients with metastatic colorectal cancer: A multicenter randomized phase II trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

Expenditures for first- and second-generation tyrosine kinase inhibitors before and after transition of imatinib to generic status

Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

New research aims to transform treatments of aggressive blood cancer

Eating ultra processed foods may speed up early signs of Parkinson's disease

Foretinib inhibits cancer stemness and gastric cancer cell proliferation by decreasing CD44 and c-MET signaling

Ropeginterferon alfa-2b vs standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): A randomised, non-inferiority, phase 3 trial and its extension study

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phase 3 trial

Long-term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic-phase chronic myeloid leukemia

Aggressive multimodal treatment and metastatic colorectal cancer survival

Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study

Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma

Bevacizumab in combination with either FOLFOX-4 or XELOX-2 in first-line treatment of patients with metastatic colorectal cancer: A multicenter randomized phase II trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

Expenditures for first- and second-generation tyrosine kinase inhibitors before and after transition of imatinib to generic status

Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

Article: Clinical Guide to Molecular Testing in Bethesda III and IV Nodules for Indian Practice

MD Clip on Diabetes & Urinary ACR: Detecting Kidney Damage Early with Dr Saraogi

New research aims to transform treatments of aggressive blood cancer

Eating ultra processed foods may speed up early signs of Parkinson's disease

Select Specialty

Select Topic